Clinicians and patients alike have lost homes and possessions, but cardiovascular care in Los Angeles remains robust.

Fitness doesn’t make people immune to atherosclerosis, but what to do with the finding in asymptomatic patients is uncertain.

Surgery is the gold standard, GLP-1s are all the rage—whether a head-to-head study is needed depends on who you ask.

Vinod Thourani and Larry Epstein explore the current field of tricuspid intervention as well as challenges within lead ...

In the year before amputation, a deep divide was seen between patients who got specialist care and those who did not.

Two new trials saw no impact of thrombolytics in reducing disability at 90 days, but some positive signals offer hope.

This month: texts fail to up adherence, unstable AF risks, survival win for SGLT2 therapy in real-world HFrEF patients, and ...

An app-based program failed to boost function for most at 3 months, but positive signs were seen in women and after CABG.

The agency says the strategy would help millions quit and prevent 4.3 million tobacco-related deaths by the end of the ...

Iulia Iatan talks to C. Michael Gibson about how a low-carbohydrate, high-protein diet can increase plasma lipid levels and cardiovascular risk.

The ARIES-HM3 substudy may help persuade implanters who are less well-versed in the circulatory changes an LVAD affords.

The two-tiered classification focuses on preclinical and clinical stages of disease, and should help inform treatment ...